Meropenem sodium/tazobactam sodium medicinal composition

A technology of tazobactam sodium and meropenem, applied in the field of medicine, can solve the problems of multidrug-resistant Acinetobacter baumannii invasion and other problems

Active Publication Date: 2012-02-15
深圳市新泰医药有限公司
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Carbapenems are the drug of choice for the treatment of severe Acinetobacter baumannii infections, but carbapenem-multidrug-resistant strains have emerged around the world in recent years, with worrying multi-drug resistance emerging from Spain to Norway The "invasion" phe...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Meropenem sodium/tazobactam sodium medicinal composition
  • Meropenem sodium/tazobactam sodium medicinal composition
  • Meropenem sodium/tazobactam sodium medicinal composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1: Study on antibacterial effect of meropenem / tazobactam sodium in vitro

[0031] 1. Materials and methods

[0032] 1. Test drugs:

[0033] (1) Meropenem (Meropenem, chemical structure is C17H25N3O5S 3H2O), chemical name 3-[[5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-(1-hydroxyethyl Base)-4-methyl-7-oxo-1-azabicyclo[3,2,0]hept-2-ene-2-carboxylic acid provided by Shenzhen Xintai Pharmaceutical Co., Ltd. Place. Lot No. 130506-200702, Potency: 93.7%

[0034] (2) Tazobactam Sodium (Tazobactam Sodium): batch number 0481-9801, potency: 93.7%. , purchased from China Institute for the Control of Pharmaceutical and Biological Products.

[0035] The following proportions are calculated by weight, where the weight of meropenem is calculated based on the dry conversion of meropenem, and the weight of tazobactam is calculated based on the dry conversion of tazobactam sodium.

[0036] 2. Test ratio:

[0037] (1) Meropenem

[0038] (2) Tazobactam sodium

[003...

Embodiment 2

[0075] Example 2: In vivo antibacterial effect of meropenem / tazobactam sodium for injection

[0076] Compositions of meropenem and tazobactam sodium in weight ratio (3:1), (2:1), (1:1), (1:2), (1:4) have certain effects on infected mice Significant antibacterial therapeutic effect.

[0077] 1. Test drug

[0078] Meropenem (Meropenem, molecular formula C17H25N3O5S 3H2O) batch number: 081212; provided by Shenzhen Xintai Pharmaceutical Co., Ltd., purchased from China Institute for the Control of Pharmaceutical and Biological Products; tazobactam sodium: batch number 0481-9801, potency: 93.7%, purchased from From the National Institute for the Control of Pharmaceutical and Biological Products.

[0079] 2 Drug preparation

[0080] Use 0.9% sodium chloride injection solution to prepare different proportions to the required concentration.

[0081] (1), meropenem (single dose)

[0082] (2), tazobactam sodium (single dose)

[0083] (3), meropenem / tazobactam sodium (3:1)

[0084]...

Embodiment 3

[0100] Example 3: Comparative study on the antibacterial effect of meropenem / tazobactam and cefoperazone / tazobactam on Acinetobacter baumannii

[0101] The combination of meropenem and tazobactam sodium in weight ratio (2:1, 1:1, 1:2, 1:4) has significant antibacterial therapeutic effect on infected mice.

[0102] 1. Test drug

[0103]Meropenem (Meropenem, chemical structure C17H25N3O5S 3H2O) was provided by Shenzhen Xintai Pharmaceutical Co., Ltd. and purchased from China National Institute for the Control of Pharmaceutical and Biological Products.

[0104] Cefoperazone / sulbactam sodium (1:1), produced by Pfizer Pharmaceutical Co., Ltd., batch number, 058354030. Provided by Shenzhen Xintai Pharmaceutical Co., Ltd.

[0105] Tazobactam sodium: batch number 0481-9801, potency: 93.7%. purchased from China National Institute for the Control of Pharmaceutical and Biological Products.

[0106] Small white mice, Kunming species, weighing 18-22g, half male and half male. Provided ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a combined medicament, in particular a meropenem tazobactam sodium combined medicament for treating infectious diseases caused by acinetobacter baumannii. The meropenem and tazobactam sodium combined medicament has a synergistic effect and an accumulative antibacterial effect on the infectious diseases caused by the acinetobacter baumannii and particularly has a good synergistic effect and a good accumulative antibacterial effect on multiple medicine-tolerant acinetobacter baumannii strains, and can be used for curing clinical infection caused by the multiple medicine-tolerant acinetobacter baumannii strains in clinic.

Description

technical field [0001] The present invention provides a combined drug, in particular, a combined drug of meropenem / tazobactam sodium for treating infectious diseases caused by Acinetobacter baumannii. It belongs to the field of medical technology. Background technique [0002] Antibiotic resistance is not a new problem, but its threat to humanity is growing. While countries are taking action, efforts are needed to avoid a return to a pre-antibiotic era, leaving the future without medicines. Therefore, the theme of World Health Day 2011 is to fight against drug resistance. [0003] Carbapenem antibiotics are a class of antibiotics with the broadest antibacterial spectrum and strong antibacterial activity so far. However, with the widespread use of carbapenems, the resistance rate of Acinetobacter baumannii to carbapenems has increased year by year. increased. And once it is resistant to carbapenems, it means that most of the commonly used broad-spectrum antibacterial drug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/431A61K31/407A61P31/04A61P11/00A61P7/00A61P13/00
Inventor 廖文广
Owner 深圳市新泰医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap